Published in Int J Cancer on April 01, 2006
Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br J Cancer (2007) 3.49
Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver (2012) 2.35
Bacteria and cancer: cause, coincidence or cure? A review. J Transl Med (2006) 1.38
Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer (2007) 1.28
Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol (2011) 1.18
Newer antibacterial drugs for a new century. Expert Opin Investig Drugs (2010) 1.16
Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract. J Exp Clin Cancer Res (2009) 1.12
Asymptomatic Gallstones (AsGS) - To Treat or Not to? Indian J Surg (2011) 1.10
Gallbladder cancer. Hepatobiliary Surg Nutr (2014) 1.10
Management strategies for gallbladder polyps: is it possible to predict malignant gallbladder polyps? Gut Liver (2008) 1.06
Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site. Int J Cancer (2013) 1.05
Population-based study to estimate prevalence and determine risk factors of gallbladder diseases in the rural Gangetic basin of North India. HPB (Oxford) (2010) 1.05
H pylori exist in the gallbladder mucosa of patients with chronic cholecystitis. World J Gastroenterol (2007) 0.99
Treatment and surveillance of polypoid lesions of the gallbladder in the United Kingdom. HPB (Oxford) (2012) 0.97
Geographic variation of gallbladder cancer mortality and risk factors in Chile: a population-based ecologic study. Int J Cancer (2008) 0.97
Does diabetes mellitus with or without gallstones increase the risk of gallbladder cancer? Results from a population-based cohort study. J Gastroenterol (2012) 0.96
Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort. Ann Oncol (2013) 0.94
Gallbladder cancer: the basics. Gastroenterol Hepatol (N Y) (2008) 0.92
Analysis of mortality rates for gallbladder cancer across the world. HPB (Oxford) (2008) 0.92
Therapy of gallstone disease: What it was, what it is, what it will be. World J Gastrointest Pharmacol Ther (2012) 0.90
Targets for current pharmacologic therapy in cholesterol gallstone disease. Gastroenterol Clin North Am (2010) 0.90
Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China. Carcinogenesis (2009) 0.90
Histopathological analysis of Salmonella chronic carriage in the mouse hepatopancreatobiliary system. PLoS One (2013) 0.89
Outcomes and prognostic factors in gallbladder cancer: a single-centre experience. Langenbecks Arch Surg (2012) 0.89
Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder. World J Gastroenterol (2010) 0.88
Cross-reactivity between immune responses to Helicobacter bilis and Helicobacter pylori in a population in Thailand at high risk of developing cholangiocarcinoma. Clin Vaccine Immunol (2008) 0.88
Xanthogranulomatous cholecystitis: a European and global perspective. HPB (Oxford) (2013) 0.87
H pylori are associated with chronic cholecystitis. World J Gastroenterol (2007) 0.87
Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary. World J Gastroenterol (2008) 0.87
HER Receptor Family: Novel Candidate for Targeted Therapy for Gallbladder and Extrahepatic Bile Duct Cancer. Gastrointest Cancer Res (2007) 0.86
Current therapy and future directions in biliary tract malignancies. Curr Treat Options Oncol (2013) 0.86
Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy. PLoS One (2012) 0.86
The impact of routine histopathological examination on cholecystectomy specimens from an Asian demographic. Ann R Coll Surg Engl (2012) 0.86
Identification of prosaposin and transgelin as potential biomarkers for gallbladder cancer using quantitative proteomics. Biochem Biophys Res Commun (2014) 0.85
Clinicopathologic features of advanced gallbladder cancer associated with adenomyomatosis. Virchows Arch (2011) 0.85
Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infect Agent Cancer (2016) 0.83
Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population. J Gastroenterol (2009) 0.83
Body Mass Index and Risk of Gallbladder Cancer: Systematic Review and Meta-Analysis of Observational Studies. Nutrients (2015) 0.83
Gall bladder carcinoma: Aggressive malignancy with protean loco-regional and distant spread. World J Clin Cases (2015) 0.83
AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines. Onco Targets Ther (2013) 0.83
Gallbladder cancer predisposition: a multigenic approach to DNA-repair, apoptotic and inflammatory pathway genes. PLoS One (2011) 0.83
Association between Helicobacter spp. infections and hepatobiliary malignancies: a review. World J Gastroenterol (2015) 0.83
Is there a role for estrogen and progesterone receptors in gall bladder cancer? HPB (Oxford) (2007) 0.82
Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances. Int J Clin Oncol (2012) 0.82
Collateral damage: insights into bacterial mechanisms that predispose host cells to cancer. Nat Rev Microbiol (2017) 0.81
Magnolol inhibits growth of gallbladder cancer cells through the p53 pathway. Cancer Sci (2015) 0.81
Missense allele of a single nucleotide polymorphism rs2294008 attenuated antitumor effects of prostate stem cell antigen in gallbladder cancer cells. J Carcinog (2013) 0.81
Risk factors of gallbladder cancer in Karachi-a case-control study. World J Surg Oncol (2011) 0.81
Expression of HER2 and bradykinin B₁ receptors in precursor lesions of gallbladder carcinoma. World J Gastroenterol (2012) 0.81
Steatocholecystitis and fatty gallbladder disease. Dig Dis Sci (2008) 0.81
Association of inflammatory and other immune markers with gallbladder cancer: Results from two independent case-control studies. Cytokine (2016) 0.81
Gallbladder carcinoma: An attempt of WHO histological classification on fine needle aspiration material. Cytojournal (2013) 0.80
Routine histopathology for carcinoma in cholecystectomy specimens not evidence based: a systematic review. Surg Endosc (2013) 0.80
Tumor characteristics and survival analysis of incidental versus suspected gallbladder carcinoma. J Gastrointest Surg (2012) 0.80
The association between BMI and gallbladder cancer risk: a meta-analysis. Oncotarget (2016) 0.80
Tumor budding and dedifferentiation in gallbladder carcinoma: potential for the prognostic factors in T2 lesions. Virchows Arch (2011) 0.80
Variants in CCK and CCKAR genes to susceptibility to biliary tract cancers and stones: a population-based study in Shanghai, China. J Gastroenterol Hepatol (2013) 0.79
Gallbladder cancer: Clinical and pathological approach. World J Clin Cases (2014) 0.79
Technical Aspects of Gallbladder Cancer Surgery. Surg Clin North Am (2016) 0.78
Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract. Br J Cancer (2008) 0.78
Rapidly progressive subcutaneous metastases from gallbladder cancer: insight into a rare presentation in gastrointestinal malignancies. J Gastrointest Oncol (2014) 0.78
Surgery for gallbladder cancer in the US: a need for greater lymph node clearance. J Gastrointest Oncol (2015) 0.78
Expression of carboxyl terminus of Hsp70-interacting protein (CHIP) indicates poor prognosis in human gallbladder carcinoma. Oncol Lett (2013) 0.78
Characteristics of gallbladder cancer in South India. Indian J Surg Oncol (2012) 0.78
Trend analysis and survival of primary gallbladder cancer in the United States: a 1973-2009 population-based study. Cancer Med (2017) 0.77
Clinicopathological features of gallbladder papillary adenocarcinoma. Medicine (Baltimore) (2014) 0.77
Expression of insulin-like growth factor I receptor as a biomarker for predicting prognosis in biliary tract cancer patients. Mol Clin Oncol (2015) 0.77
Regional differences in gallbladder cancer pathogenesis: insights from a comparison of cell cycle-regulatory, PI3K, and pro-angiogenic protein expression. Ann Surg Oncol (2012) 0.77
Comparison of the gene expression profiles between gallstones and gallbladder polyps. Int J Clin Exp Pathol (2014) 0.77
A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer. Gut Liver (2013) 0.76
Role of cholecystectomy and lymph node dissection in patients with T2 gallbladder cancer. World J Surg (2013) 0.76
Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile. Future Oncol (2014) 0.76
Annexin A4-nuclear factor-κB feedback circuit regulates cell malignant behavior and tumor growth in gallbladder cancer. Sci Rep (2016) 0.75
Variants and haplotypes in Flap endonuclease 1 and risk of gallbladder cancer and gallstones: a population-based study in China. Sci Rep (2015) 0.75
Parity and risk of death from gallbladder cancer among a cohort of premenopausal parous women in Taiwan. Int J Environ Res Public Health (2015) 0.75
RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancer. Oncotarget (2016) 0.75
Cytopathological diagnosis of gallbladder mass and mural thickening based on imaging findings: A prospective study of 51 cases. J Cytol (2016) 0.75
KRAS Mutation as a Potential Prognostic Biomarker of Biliary Tract Cancers. Jpn Clin Med (2016) 0.75
Association between shift work and the risk of death from biliary tract cancer in Japanese men. BMC Cancer (2015) 0.75
Epidemiological factors in gall bladder cancer in eastern India-a single centre study. Indian J Surg Oncol (2012) 0.75
Diet and biliary tract cancer risk in Shanghai, China. PLoS One (2017) 0.75
The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer. Oncotarget (2016) 0.75
Chemotherapy Compared with Best Supportive Care for Metastatic/Unresectable Gallbladder Cancer: a Non-randomized Prospective Cohort Study. Indian J Surg Oncol (2015) 0.75
Cancer of the gallbladder-Chilean statistics. Ecancermedicalscience (2016) 0.75
Prospective Study of Glycemic Load, Glycemic Index, and Carbohydrate Intake in Relation to Risk of Biliary Tract Cancer. Am J Gastroenterol (2016) 0.75
Colorectal Liver Metastasis, Primary Gallbladder Carcinoma and Myelofibrosis Present Simultaneously in a Liver Resection Specimen. Case Rep Gastroenterol (2015) 0.75
A case report of the clear cell variant of gallbladder carcinoma. Int J Surg Case Rep (2017) 0.75
Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer. Cancer Res Treat (2014) 0.75
Primary Pure Squamous Cell Carcinoma of the Gallbladder Locally Invading the Liver, Duodenum, and Stomach: A Case Report and Literature Review. Case Rep Surg (2017) 0.75
Breast metastasis from recurrent gallbladder adenocarcinoma: a case report with review of the literature. J Gastrointest Oncol (2016) 0.75
Exfoliative erythroderma as a paraneoplastic presentation of adenocarcinoma of the gallbladder. J Gastrointest Oncol (2015) 0.75
Estimation of life expectancy of patients diagnosed with the most common cancers in the Valparaiso Region, Chile. Ecancermedicalscience (2017) 0.75
Incidental non-benign gallbladder histopathology after cholecystectomy in an United Kingdom population: Need for routine histological analysis? World J Gastrointest Surg (2016) 0.75
Gallbladder Carcinoma in the United States: A Population Based Clinical Outcomes Study Involving 22,343 Patients from the Surveillance, Epidemiology, and End Result Database (1973-2013). HPB Surg (2017) 0.75
Subversion of host genome integrity by bacterial pathogens. Nat Rev Mol Cell Biol (2016) 0.75
Clinicopathologic Differences in Patients with Gallbladder Cancer According to the Presence of Anomalous Biliopancreatic Junction. World J Surg (2016) 0.75
Long non-coding RNA expression profiles in gallbladder carcinoma identified using microarray analysis. Oncol Lett (2017) 0.75
A Month for Gallbladder Cancer: A Case Report of Four Gallbladder Cancers Over a 30-Day Period at a Community Hospital. World J Oncol (2015) 0.75
An Interesting Case of a Bilious Pleural Effusion. J Investig Med High Impact Case Rep (2017) 0.75
Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med (2002) 10.80
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer (2007) 10.29
Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev (2005) 9.47
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol (2012) 9.28
Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ (2010) 7.00
Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst (2005) 6.69
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst (2003) 6.28
A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med (2004) 6.24
Global burden of human papillomavirus and related diseases. Vaccine (2012) 5.48
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer (2011) 5.43
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol (2009) 5.05
Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet (2002) 5.00
Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst (2007) 4.55
Epidemiology and risk factors of urothelial bladder cancer. Eur Urol (2012) 4.45
Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer (2009) 4.28
Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem (2005) 4.18
Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst (2006) 4.14
Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet (2002) 3.96
Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology (2010) 3.86
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood (2008) 3.81
Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS (2006) 3.76
Recent patterns in gastric cancer: a global overview. Int J Cancer (2009) 3.75
False-positive results in cancer epidemiology: a plea for epistemological modesty. J Natl Cancer Inst (2008) 3.72
Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine (2006) 3.72
Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev (2005) 3.40
Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer (2012) 3.35
Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev (2009) 3.33
Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology (2007) 3.22
Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol (2005) 3.18
Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol (2013) 3.00
Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev (2005) 2.86
Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst (2002) 2.75
Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet (2003) 2.71
Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis (2004) 2.63
Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol (2010) 2.61
Smoking in Italy 2005-2006: effects of a comprehensive National Tobacco Regulation. Prev Med (2007) 2.61
Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. J Clin Oncol (2014) 2.57
Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies. Lancet Oncol (2011) 2.52
Correlation among pathology, genotype, and patient outcomes in glioblastoma. J Neuropathol Exp Neurol (2006) 2.51
Age as a predictive factor in glioblastomas: population-based study. Neuroepidemiology (2009) 2.44
Glycemic index: overview of implications in health and disease. Am J Clin Nutr (2002) 2.43
Dietary zinc and prostate cancer risk: a case-control study from Italy. Eur Urol (2007) 2.41
Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population. J Natl Cancer Inst (2007) 2.36
A further plea for adherence to the principles underlying science in general and the epidemiologic enterprise in particular. Int J Epidemiol (2009) 2.35
Risk of prostate, breast and colorectal cancer after skin cancer diagnosis. Int J Cancer (2008) 2.28
Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int J Cancer (2008) 2.17
Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control (2008) 2.17
Worldwide mortality from cirrhosis: an update to 2002. J Hepatol (2007) 2.16
Vinyl chloride exposure and cirrhosis: a systematic review and meta-analysis. Dig Liver Dis (2012) 2.15
Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood (2009) 2.15
Mechanisms of disease: The epidemiology of bladder cancer. Nat Clin Pract Urol (2006) 2.13
Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology (2008) 2.11
Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya. Int J Cancer (2008) 2.11
The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis (2005) 2.07
Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol (2003) 2.03
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer (2008) 2.01
The burden of cancer attributable to alcohol drinking. Int J Cancer (2006) 2.01
Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Int J Epidemiol (2008) 2.00
Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control study. Cancer Causes Control (2003) 2.00
Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000. Int J Cancer (2005) 1.98
Relation of dietary glycemic load with ischemic and hemorrhagic stroke: a cohort study in Greece and a meta-analysis. Eur J Nutr (2014) 1.98
Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case-control studies. Am J Epidemiol (2009) 1.97
Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am J Epidemiol (2003) 1.96
Time from adenosine di-phosphate receptor antagonist discontinuation to coronary bypass surgery in patients with acute coronary syndrome: meta-analysis and meta-regression. Int J Cardiol (2013) 1.94
Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol (2008) 1.91
Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update. Eur J Cardiovasc Prev Rehabil (2009) 1.90
Reproducibility of skin characteristic measurements and reported sun exposure history. Int J Epidemiol (2002) 1.88
Oral cancer in southern India: the influence of smoking, drinking, paan-chewing and oral hygiene. Int J Cancer (2002) 1.87
Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis. Clin Gastroenterol Hepatol (2013) 1.87
Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev (2005) 1.87
Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab (2004) 1.86
Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev (2010) 1.85
Trends in mortality from urologic cancers in Europe, 1970-2008. Eur Urol (2011) 1.85
Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the Republic of Korea. Am J Trop Med Hyg (2006) 1.83
Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev (2012) 1.82
Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett (2008) 1.80
Cancer risk associated with alcohol and tobacco use: focus on upper aero-digestive tract and liver. Alcohol Res Health (2006) 1.80
Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. Oncologist (2012) 1.79
Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer (2008) 1.78
Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev (2006) 1.77
Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico. Int J Cancer (2006) 1.75
Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Am J Epidemiol (2013) 1.73
Dietary folate and risk of prostate cancer in Italy. Cancer Epidemiol Biomarkers Prev (2005) 1.72
Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study. Haematologica (2004) 1.72
Human papillomavirus infection among women in South and North Vietnam. Int J Cancer (2003) 1.71
Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer (2003) 1.71